Primary hepatocytes as targets for Hepatitis C virus replication

par Farquhar, M J, McKeating, J A
Publié 2008

Differential effect of p7 inhibitors on hepatitis C virus cell-to-cell transmission()

par Meredith, L.W., Zitzmann, N., McKeating, J.A.
Publié 2013

Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.

par McKeating, J A, McKnight, A, Moore, J P
Publié 1991

Identification and characterization of monoclonal antibodies specific for polymorphic antigenic determinants within the V2 region of the human immunodeficiency virus type 1 envelop...

par Shotton, C, Arnold, C, Sattentau, Q, Sodroski, J, McKeating, J A
Publié 1995

TNF superfamily members promote hepatitis C virus entry via an NF-κB and myosin light chain kinase dependent pathway

par Fletcher, N. F, Clark, A. R, Balfe, P, McKeating, J. A
Publié dans J Gen Virol (2017)

Development of a Neutralizing Antibody Response during Acute Primary Human Immunodeficiency Virus Type 1 Infection and the Emergence of Antigenic Variants

par Lewis, J., Balfe, P., Arnold, C., Kaye, S., Tedder, R. S., McKeating, J. A.
Publié 1998

Direct measurement of soluble CD4 binding to human immunodeficiency virus type 1 virions: gp120 dissociation and its implications for virus-cell binding and fusion reactions and th...

par Moore, J P, McKeating, J A, Norton, W A, Sattentau, Q J
Publié 1991

Virions of primary human immunodeficiency virus type 1 isolates resistant to soluble CD4 (sCD4) neutralization differ in sCD4 binding and glycoprotein gp120 retention from sCD4-sen...

par Moore, J P, McKeating, J A, Huang, Y X, Ashkenazi, A, Ho, D D
Publié 1992

Resistance of a human serum-selected human immunodeficiency virus type 1 escape mutant to neutralization by CD4 binding site monoclonal antibodies is conferred by a single amino ac...

par McKeating, J A, Bennett, J, Zolla-Pazner, S, Schutten, M, Ashelford, S, Brown, A L, Balfe, P
Publié 1993

Length polymorphism within the second variable region of the human immunodeficiency virus type 1 envelope glycoprotein affects accessibility of the receptor binding site.

par Fox, D G, Balfe, P, Palmer, C P, May, J C, Arnold, C, McKeating, J A
Publié 1997

Comparison of nucleic acid and protein immunization for induction of antibodies specific for HIV-1 gp120

par PEET, N M, McKEATING, J A, RAMOS, B, KLONISCH, T, DE SOUZA, J B, DELVES, P J, LUND, T
Publié 1997

Conformational epitope on gp120 important in CD4 binding and human immunodeficiency virus type 1 neutralization identified by a human monoclonal antibody.

par Ho, D D, McKeating, J A, Li, X L, Moudgil, T, Daar, E S, Sun, N C, Robinson, J E
Publié 1991

Characterization of neutralizing monoclonal antibodies to linear and conformation-dependent epitopes within the first and second variable domains of human immunodeficiency virus ty...

par McKeating, J A, Shotton, C, Cordell, J, Graham, S, Balfe, P, Sullivan, N, Charles, M, Page, M, Bolmstedt, A, Olofsson, S
Publié 1993

Neutralizing antibody response during acute and chronic hepatitis C virus infection

par Logvinoff, C., Major, M. E., Oldach, D., Heyward, S., Talal, A., Balfe, P., Feinstone, S. M., Alter, H., Rice, C. M., McKeating, J. A.
Publié 2004

Lentiviral hepatitis B pseudotype entry requires sodium taurocholate co-transporting polypeptide and additional hepatocyte-specific factors

par Meredith, L. W., Hu, K., Cheng, X., Howard, C. R., Baumert, T. F., Balfe, P., van de Graaf, K. F., Protzer, U., McKeating, J. A.
Publié dans J Gen Virol (2016)

Diverse Hepatitis C Virus Glycoproteins Mediate Viral Infection in a CD81-Dependent Manner

par McKeating, J. A., Zhang, L. Q., Logvinoff, C., Flint, M., Zhang, J., Yu, J., Butera, D., Ho, D. D., Dustin, L. B., Rice, C. M., Balfe, P.
Publié 2004

Hepatoma polarization limits CD81 and hepatitis C virus dynamics

par Harris, H J, Clerte, C, Farquhar, M J, Goodall, M, Hu, K, Rassam, P, Dosset, P, Wilson, G K, Balfe, P, IJzendoorn, S C, Milhiet, P E, McKeating, J A
Publié 2013